These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2170584)

  • 1. Vesicular changes in the myopathies of AIDS. Ultrastructural observations and their relationship to zidovudine treatment.
    Panegyres PK; Papadimitriou JM; Hollingsworth PN; Armstrong JA; Kakulas BA
    J Neurol Neurosurg Psychiatry; 1990 Aug; 53(8):649-55. PubMed ID: 2170584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished?
    Simpson DM; Citak KA; Godfrey E; Godbold J; Wolfe DE
    Neurology; 1993 May; 43(5):971-6. PubMed ID: 8492955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial myopathy associated with chronic zidovudine therapy in AIDS.
    Peters BS; Winer J; Landon DN; Stotter A; Pinching AJ
    Q J Med; 1993 Jan; 86(1):5-15. PubMed ID: 8438050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial cytochrome c oxidase deficiency and cytoplasmic bodies in patients with zidovudine myopathy.
    Chariot P; Gherardi R
    Neuromuscul Disord; 1991; 1(5):357-63. PubMed ID: 1668320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult onset nemaline myopathy: a distinct nosologic entity?
    Palmucci L; Doriguzzi C; Mongini T; Chiadò-Piat L
    Clin Neuropathol; 1993; 12(3):153-5. PubMed ID: 8391957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial myopathy caused by long-term zidovudine therapy.
    Dalakas MC; Illa I; Pezeshkpour GH; Laukaitis JP; Cohen B; Griffin JL
    N Engl J Med; 1990 Apr; 322(16):1098-105. PubMed ID: 2320079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear and mitochondrial changes of muscle fibers in AIDS after treatment with high doses of zidovudine.
    Schröder JM; Bertram M; Schnabel R; Pfaff U
    Acta Neuropathol; 1992; 85(1):39-47. PubMed ID: 1285495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine therapy.
    Grau JM; Masanés F; Pedrol E; Casademont J; Fernández-Solá J; Urbano-Márquez A
    Ann Neurol; 1993 Aug; 34(2):206-11. PubMed ID: 8338345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myopathy in HIV infection: the role of zidovudine and the significance of tubuloreticular inclusions.
    Lane RJ; McLean KA; Moss J; Woodrow DF
    Neuropathol Appl Neurobiol; 1993 Oct; 19(5):406-13. PubMed ID: 8278024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A benign form of reducing body myopathy.
    Oh SJ; Meyers GJ; Wilson ER; Alexander CB
    Muscle Nerve; 1983 May; 6(4):278-82. PubMed ID: 6306460
    [No Abstract]   [Full Text] [Related]  

  • 11. Muscle disease, HIV and zidovudine: the spectrum of muscle disease in HIV-infected individuals treated with zidovudine.
    Manji H; Harrison MJ; Round JM; Jones DA; Connolly S; Fowler CJ; Williams I; Weller IV
    J Neurol; 1993 Sep; 240(8):479-88. PubMed ID: 8263554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nature of muscular change in osteomalacia: light- and electron-microscope observations.
    Dastur DK; Gagrat BM; Wadia NH; Desai M; Bharucha EP
    J Pathol; 1975 Dec; 117(4):211-28. PubMed ID: 1214191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus-associated myopathy: analysis of 11 patients.
    Simpson DM; Bender AN
    Ann Neurol; 1988 Jul; 24(1):79-84. PubMed ID: 2843080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distal myopathy: electron microscopic and histochemical studies.
    Markesbery WR; Griggs RC; Herr B
    Neurology; 1977 Aug; 27(8):727-35. PubMed ID: 196233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tubular aggregates and partial cytochrome c oxidase deficiency in skeletal muscle of patients with AIDS treated with zidovudine.
    Chariot P; Benbrik E; Schaeffer A; Gherardi R
    Acta Neuropathol; 1993; 85(4):431-6. PubMed ID: 8386898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AZT myopathy and HIV-1 polymyositis: one disease or two?
    Walsh K; Kaye K; Demaerschalk B; Stewart S; Crukley J; Hammond R
    Can J Neurol Sci; 2002 Nov; 29(4):390-3. PubMed ID: 12463497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of neuromuscular pathology in acquired immune deficiency syndrome patients with cytomegalovirus infection and zidovudine treatment.
    Cornford ME; Ho HW; Vinters HV
    Acta Neuropathol; 1992; 84(5):516-29. PubMed ID: 1334328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early features of zidovudine-associated myopathy: histopathological findings and clinical correlations.
    Cupler EJ; Danon MJ; Jay C; Hench K; Ropka M; Dalakas MC
    Acta Neuropathol; 1995; 90(1):1-6. PubMed ID: 7572071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction.
    Mhiri C; Baudrimont M; Bonne G; Geny C; Degoul F; Marsac C; Roullet E; Gherardi R
    Ann Neurol; 1991 Jun; 29(6):606-14. PubMed ID: 1892364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural characteristics and DNA immunocytochemistry in human immunodeficiency virus and zidovudine-associated myopathies.
    Pezeshkpour G; Illa I; Dalakas MC
    Hum Pathol; 1991 Dec; 22(12):1281-8. PubMed ID: 1748434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.